Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

484 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.
Wheeland RG, Dhawan S. Wheeland RG, et al. Among authors: dhawan s. J Drugs Dermatol. 2011 Jun;10(6):596-602. J Drugs Dermatol. 2011. PMID: 21637900 Clinical Trial.
At week 8, more than 90 percent of subjects reported improvements in their skin's overall appearance, clarity, radiance, tone, texture and smoothness. ...
At week 8, more than 90 percent of subjects reported improvements in their skin's overall appearance, clarity, radiance, tone, textur …
Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.
Dhawan SS, Blyumin ML, Pearce DJ, Feldman SR. Dhawan SS, et al. J Drugs Dermatol. 2005 Mar-Apr;4(2):228-30. J Drugs Dermatol. 2005. PMID: 15776784
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E, Dhawan S, Torok H, Kircik L. Tanghetti E, et al. Among authors: dhawan s. Dermatol Online J. 2007 Jul 13;13(3):1. Dermatol Online J. 2007. PMID: 18328195 Clinical Trial.
Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E, Kircik L, Wilson D, Dhawan S. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2008 Jun;7(6):534-8. J Drugs Dermatol. 2008. PMID: 18561583 Clinical Trial.
Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS. Dhawan SS. Cutis. 2009 May;83(5):265-72. Cutis. 2009. PMID: 19537284 Clinical Trial.
Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Kircik L, Green L, Thiboutot D, Tanghetti E, Wilson D, Dhawan S, Parr L. Kircik L, et al. Among authors: dhawan s. J Drugs Dermatol. 2009 Sep;8(9):812-8. J Drugs Dermatol. 2009. PMID: 19746673 Clinical Trial.
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.
Patients treated with tazarotene 0.1% cream performed better in many acne efficacy measures (reduction in lesion counts, percentage of patients achieving a 50 percent lesion count reduction, overall disease severity, investigator's global assessment) than did patients trea …
Patients treated with tazarotene 0.1% cream performed better in many acne efficacy measures (reduction in lesion counts, percentage of patie …
Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z. Tanghetti E, et al. Among authors: dhawan s. J Drugs Dermatol. 2011 Jul;10(7):783-92. J Drugs Dermatol. 2011. PMID: 21720661 Clinical Trial.
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Dhawan SS, Gwazdauskas J. Dhawan SS, et al. Cutis. 2013 Feb;91(2):99-104. Cutis. 2013. PMID: 23513559 Clinical Trial.
Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold M, Dhawan S, Verma A, Kuligowski M, Dobrowski D. Gold M, et al. Among authors: dhawan s. J Drugs Dermatol. 2016 Jun 1;15(6):743-8. J Drugs Dermatol. 2016. PMID: 27272083 Clinical Trial.
484 results
Jump to page
Feedback